Objectives: Early effective treatment and appropriate coverage are vital for full-thickness wounds. Amnion membrane-derived products have recently emerged in tissue engineering. However, the optimal concentration, carrier for controlled release, and handling have remained challenges. This study aims to develop and optimize an forming, amniotic-based hydrogel for wound healing.

Materials And Methods: Here, a composite matrix was fabricated with gelatin hydrogel modified with methacrylate functional group conjugated (GelMA) and keratose (wt.1%), loaded with mesenchymal stem cells (MSCs, 1×10 cell/ml) and optimized soluble amniotic membrane (SAM, 0.5 mg/ml). The physicochemical properties of the final subject were evaluated and environments.

Results: The results of the assay demonstrated that conjugation of the methacryloyl group with gelatin resulted in the formation of GelMA hydrogel (26.7±1.2 kPa) with higher mechanical stability. Modification of GelMA with a glycosaminoglycan sulfate (Keratose) increased controlled delivery of SAM (47.3% vs. 84.3%). Metabolic activity (93%) and proliferation (21.2 ± 1.5 µg/ml) of MSCs encapsulated in hydrogel improved by incorporation of SAM (0.5 mg/ml). Furthermore, the migration of fibroblasts was facilitated in the scratched assay by SAM (0.5 mg/ml)/MSCs (1×10 cell/ml) conditioned medium. The GelMA hydrogel groupes revealed regeneration of full-thickness skin defects in rats after 3 weeks due to the high angiogenesis (6.3 ± 0.3), cell migration, and epithelialization.

Conclusion: The results indicated in situ forming and tunable GelMA hydrogels containing SAM and MSCs could be used as efficient substrates for full-thickness wound regeneration.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11193504PMC
http://dx.doi.org/10.22038/IJBMS.2024.74290.16140DOI Listing

Publication Analysis

Top Keywords

soluble amniotic
8
amniotic membrane
8
full-thickness wound
8
wound regeneration
8
1×10 cell/ml
8
sam mg/ml
8
gelma hydrogel
8
hydrogel
6
gelma
5
sam
5

Similar Publications

Human birth tissue products as a non-opioid medicine to inhibit post-surgical pain.

Elife

December 2024

Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University, School of Medicine, Baltimore, United States.

Pain after surgery causes significant suffering. Opioid analgesics cause severe side effects and accidental death. Therefore, there is an urgent need to develop non-opioid therapies for managing post-surgical pain.

View Article and Find Full Text PDF

The human fetal membrane is a globally accepted biological biomaterial for wound and tissue repair and regeneration in numerous fields, including dermatology, ophthalmology, and more recently orthopedics, maxillofacial and oral surgery, and nerve regeneration. Both cells and matrix components of amnion and chorion are beneficial, releasing a diverse range of growth factors, cytokines, peptides, and soluble extracellular matrix components. Beside fetal membranes, numerous natural materials have also been reported to promote wound healing.

View Article and Find Full Text PDF

The biologics derived from human amniotic membranes (AMs) demonstrate potential pain-inhibitory effects in clinical settings. However, the molecular basis underlying this therapeutic effect remains elusive. HC-HA/PTX3 is a unique water-soluble regenerative matrix that is purified from human AMs.

View Article and Find Full Text PDF

Revisiting the human umbilical cord epithelium. An atypical epithelial sheath with distinctive features.

Cell Tissue Res

December 2024

Laboratory for Stem Cells and Reproductive Cell Biology, Department of Histology and Embryology, Ankara University School of Medicine, Sihhiye, 06410, Ankara, Turkey.

The umbilical cord epithelium (UCE) is the surface tissue that covers the umbilical cord (UC). It is widely considered a single-layered epithelium composed of squamous or cuboidal cells, which are in constant contact with amniotic fluid. The objective of this study was to elucidate the distinctive structural characteristics and abundance of specific proteins in this unique epithelium, many of which have not been previously demonstrated.

View Article and Find Full Text PDF
Article Synopsis
  • Osteoarthritis is a common degenerative joint condition, especially in older adults, characterized by the breakdown of cartilage leading to pain and disability, influenced by factors like age, obesity, and trauma.
  • Recent research focuses on the use of cell therapy, particularly mesenchymal stem cells, to regenerate cartilage affected by osteoarthritis through co-culture experiments with other stem cells.
  • The study found that mesenchymal stem cells and their secretome significantly enhance the expression of articular cartilage-specific genes and proteins, suggesting their potential as an effective treatment for cartilage regeneration.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!